IGUCHI KIMI 4
4 · Sage Therapeutics, Inc. · Filed Jan 5, 2023
Insider Transaction Report
Form 4
IGUCHI KIMI
See Remarks
Transactions
- Exercise/Conversion
Common Stock
2023-01-04$1.36/sh+1,800$2,448→ 58,024 total - Exercise/Conversion
Stock Option (Right to Buy)
2023-01-04−1,800→ 7,242 totalExercise: $1.36Exp: 2024-01-22→ Common Stock (1,800 underlying)
Footnotes (2)
- [F1]Reflects beneficial ownership balance which includes 427 shares purchased on June 30, 2022 and 197 shares purchased on December 31, 2022, each under the Sage Therapeutics, Inc. 2014 Employee Stock Purchase Plan.
- [F2]The stock option award was issued pursuant to the Sage Therapeutics, Inc. 2011 Stock Option and Incentive Plan. The option vested in full on July 23, 2016.